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INVESTIGATIONS into the relationship between cell proliferation and overall
tumour growth rate in human cancer have to contend with the major limitation
that only rarely can both cell kinetic data and information on volume growth
rate be obtained in one and the same patient. When a case is operable it is usually
inadvisable to delay treatment in order to estimate growth rate; when, for instance
in the case of lung secondaries, it is right to leave tumours untreated, tissue
specimens are seldom available.
It was to overcome this limitation that the present investigations were begun.
In many cases of malignant disease in domestic animals the natural history and
histopathological features are very similar to human cancer and in a proportion
of these cases it is permissible to observe the course of the disease and perform
simple investigations before treatment or euthanasia. The present communica-
tion covers the first nine cases which have been studied in this project.
The available data on the overall growth rate of untreated tumours in man
have been reviewed by Steel and Lamerton (1966). The cases from which these
data have been obtained form a highly selected group and one must be cautious
in taking them to be typical of the majority of tumours, especially tumours in
other anatomical sites. Some idea of the distribution of human tumour volume
doubling times can be gained from the histogram shown in Fig. 1. This histogram
shows the spread of 175 measurements ofhuman tumour growth rate; 135 ofthese
were metastatic deposits in the lung (Collins, 1962; Collins, Loeffler and Tivey,
1956; Breur, 1966); 34 were primary lung tumours; 6 were primary bone tumours
(Spratt, 1965). The mean values for these three classes of tumour are not sig-
nificantly different. The median volume doubling time of the whole group is
66 days and 90% ofthe values fall in the range 16-253 days.
Cell proliferation studies by the method oflabelled mitoses have at the present
time only been reported in two series of cases of human cancer. Clarkson et al.
(1965) has described detailed kinetic studies on neoplastic effusions in six cases.
Frindel et al. (1968) have reported their investigations on five superficial solid
tumours. Many more cases are recorded in which a thymidine labelling index
has been determined, either by in vivo or by in vitro thymidine administration.
These have been summarised by Steel and Lamerton (1966) and compared with
the available data on human tumour growth rate. The conclusion from this work
was that in the majority ofhuman tumours, cell loss could be the dominant factor
determining growth rate. The same conclusion has been reached by Iversen
(1967) and Refsum and Berdal (1967) on the basis of measurements of mitotic
rate in tumours of the head and neck by the colchicine method; their calculations
implied that the rate of cell loss must in their sample of tumours be in excess of
90% of the rate of cell production.L. N. OWEN AND G. G. STEEL
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FIGc. 1.-The distribution of volume doubling times for tumours in man and in domestic
animals. The human data are collected from the literature (Steel, 1967). The animal
data are from the present study: the numbers indicate the case number of individual lung
metastases or primary tumours; for cases 6 and 9 the range of doubling times is shown.
The main source of uncertainty in both of these estimates of cell loss from
human tumours probably lies in the fact that the growth rate and cell kinetic
data had to be taken from different series of cases. The object of the present
studies on spontaneous tumours in domestic animals was to study thymidine
labelling in tumours of known growth rate and also to gather data on the overall
growth rate of tumours in species which are intermediate in size and longevity
between man and laboratory animals.
MEASUREMENTS OF TUMOUR GROWTH RATE
Access to dogs
Dogs with malignant neoplasms have been admitted to the Cambridge Univer-
sity Veterinary Hospital for surgical or radiotherapeutic treatment. When lung
metastases developed the general health ofthe animal was usually not immediately
affected and in some cases it has been possible to take serial radiographs of the
chest before euthanasia became necessary.
Details of X-ray procedure
Radiographs were made on a machine with a tube distance of 75 cm. In most
instances a Potter-Buckey diaphragm was used and for the larger dogs a Schoen-
ander grid was found to be an advantage. A standard arrangement was used for
each dog.
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In cases 1 and 2, forced inspiration was used to improve the radiographic
demonstration of metastases. Dogs were premedicated with atropine sulphate
0-65 mg. and acetyl-promazine 0.5 to 3 mg. intramuscularly. Anaesthesia was
induced with methohexitone sodium (Brietal) and maintained with nitrous oxide
and oxygen, deepened with halothane ifrequired. A semi-open to and fro Magill
tube was used, the expiratory valve being completely or partially closed, and the
rebreathing bag compressed manually. After chest radiography the dog was
allowed to recover and was usually able to walk in 10 to 15 minutes. The tech-
nique could thus be used successfully on an outpatient basis.
Radiographs in a lateral and postero-anterior plane were taken but the lateral
radiographs proved to be more valuable in this study.
Method ofmeasuring metastases on radiographs
Simple Vernier callipers were used to measure the pulmonary metastases as
outlined on the radiographs. Most of the metastases measured were round but
in a few cases one diameter was slightly larger than the other. The use of a
transparent plastic rule on which circles of increasing diameter were engraved
was found to be an advantage (Breur, 1966). Tumour volume was computed as
Ir/6 times the cube ofthe mean diameter. Growth curves (Fig. 2) were plotted on
semi-logarithmic paper and the doubling time recorded in Table I was that defined
by the last few experimental points.
TABLE I
Case Tumour
1 . Secondaries (1)
(2)
(3)
(4)
2 . Primary
Secondaries (1)
(2)
3 . Secondaries (1)
(2)
(3)
4 . Primary
6 . Secondaries
7 . Secondaries (1)
(2)
(3)
(4)
8 . Primary
Secondaries (1)
(2)
(3)
(4)
9 . 7 Secondaries
Volume
doubling Labelling
time index
(days) (%)
22 . 3-3
(6.8) . 6-6
6-8 . 5.3
6*5 . 3-4
80 . 5*0
150 . 4-6
60 . 6-2
17 . 6-9
15 . 7.9
12 . 8*3
38 . 6.9
10 . 10-8
20 . 9*0
(range
7-25 days)
16 . 3*6
16 . 1X4
(16) . 1-6
18 . 2X6
(25)
40
(40) <1-0
40 .J
mean of . 9 7
24 days
Potential
doubling
time
(days)
7-6
3 8
4.7
7.4
5*0
5.5
4 0
3 6
3*2
3 0
3. 6
2@3
2 8
7 0
14
16
9*6
Cell loss factor
(%) Grade
66 . m
44 . II
31 . II
0 . I
94 . IV
96 . IV
93 . IV
79 . I1:
79 . III
75 . m
90 . IV
77 . III
86 . III
56
12
0
47
m
I
I
II
I
2*6 89 . III
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FjIG. 2.-Growth curves of lung metastases (solid lines) and primary tumours (broken lines)
for tumours in domestic animals.
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Case 1
Terrier. Male. Age 16 months. Weight 64 kg. Thymidine dose 2 mCi.
A fibro-sarcoma in the right lumbar region, not involving bone, was excised two
months after it was first noticed. There was obvious recurrence of this primary
tumour within 3 weeks of surgery and shortly after this metastases were visible
radiographically in the lungs.
Measurements of tumour volume were made on six occasions over a period of
41 days. The secondary tumour numbered (1) (Table I) was visible throughout
this period and had a doubling time of 22 days. Secondaries (3) and (4) were not
seen on the earlier radiographs; on the later ones both had doubling times of 6-8
days. The three measurements on secondary (2) do not allow a reliable doubling
time to be estimated but they are consistent with the figure of 6-8 days.
This case is an exception to the generalisation that multiple lung secondaries
usually have comparable growth rates (Breur, 1966; Smithers, 1968). The
metastasis which was radiographically visible first was, at the time of death, the
smallest of the four which were measurable.
Case 2
Alsation. Male. Age 9 years. Weight 30 kg. Thymidine dose 6 mCi.
When seen, the animal had been lame 3 months on the right fore limb. A diag-
nosis of sclerotic osteosarcoma of the right radius and ulna was made. Therapy
was attempted using an intravenous injection of tritiated " Synkavit ". It was
appreciated that the residual tritium from this injection might confuse the tritiated
thymidine autoradiographs. In fact, after the delay of 18 weeks, the only evi-
dence ofthe H3-Synkavit was diffuse labelling in and around necrotic regions. It
seemed justifiable to measure the thymidine labelling index by counting those
cells which showed only nuclear labelling.
The growth curve for the primary tumour showed a negligible response to
Synkavit therapy. Up to 70 days after therapy the doubling time was about 40
days, though the final measurement suggests that this may have more than
doubled by the time of death.
Secondary (1) was clearly reduced in size as a result of therapy. It soon
regrew, however, and finally had a doubling time of 150 days. Secondary (2)
was not visible before therapy. Its growth rate gradually decreased and the
terminal doubling time was about 60 days.
Case 3
Retriever. Male. Age 5 years. Weight 31 kg. Thymidine dose 6 mCi. A
spindle-cell sarcoma of the soft tissues of the right carpal region was diagnosed
and given 1200 R of X-irradiation. The tumour regressed but recurred 8 months
later when it was irradiated with 1000 R. Metastases in the lungs were present at
this time.
Chest radiographs were taken on six occasions in the period of 5 weeks before
death. Three secondaries could be measured throughout this period. The
growth curves were not exponential and there is some uncertainty in the estimates
of terminal growth rate, but it seems possible that secondary (3) had a shorter
doubling time (about 12 days) than secondaries (1) and (2) (about 16 days).
41
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Case 4
Ginger neutered male cat. Age 13 years. Weight 3 kg. Thymidine dose
0-6 mCi. A non-painful hard irregular swelling on the left 6th rib was excised but
recurred 5 weeks later. Histological examination showed the tumour to be an
osteosarcoma.
The measurements of the primary tumour were made partly by vernier
calipers (width measurement) and partly from radiographs (length and depth).
The depth measurement was particularly uncertain. The estimate of 38 days for
the volume doubling time is therefore probably less precise than for many of the
lung secondaries in the present series of cases.
Case 5
Cross-bred Scottish terrier. Bitch. Age 10 years. Weight 18 kg. Thymi-
dine dose 3-5 mCi. This animal had a diffuse anaplastic mammary carcinoma
with gross infiltration of the skin. The tumour had been known to be present at
least 2 months.
No estimate ofthe rate ofgrowth was possible in this case.
Case 6
Blue roan Cocker Spaniel. Male, Age 11 years. Weight 10 kg. Thymidine
dose 4 mCi. An ulcerated melanoma on the gum adjacent to the left mandibular
canine was excised but recurred within 2 months. At the time of recurrence,
radiographic examination showed lung metastases.
The measurements of growth rate in case 6 were the most detailed of all the
cases in the present series. It was possible to obtain growth curves on 11 lung
secondaries, varying over a total size range of0403 c.c. to 6-4 c.c. These presented
a range ofterminal volume doubling times, but it was noticeable that seven formed
a relatively uniform group (12.4, 12-5, 13-4, 14-0, 14-6, 15-0, 15-5 days) while two
were considerably faster than the main group (7.0 and 7-5 days) and two were
slower (22.6 and 24-0 days). It then became clear that there was also a size
difference between these three groups (their mean growth curves are shown in
Fig. 2): the main group had a mean terminal volume of 2-53 c.c., the faster group
1-37 c.c. and the slower group 5-6 c.c. The implication is that within the whole
group of lung secondaries in this animal, size and volume doubling time were
positively correlated and furthermore that all the secondaries might well be
following the same non-exponential growth curve. The situation is that which
would be expected if the various metastases were initiated at different times but
followed the same growth curve, some being found earlier in their growth than
others. It is possible to reproduce a portion ofsuch a growth curve by translating
the individual curves in time until the points fall on a smooth curve. The curve
obtained by this procedure is shown in Fig. 3. It has a doubling time of 7 days
at first, increasing to 25 days for the larger tumours, as would be expected from
the individual doubling time values quoted above.
As can be seen from the photograph of the post-mortem specimen (Fig. 4) the
secondaries from this tumour were highly pigmented. This to some extent made
the counting of the autoradiographs difficult. Although under the microscope
the black silver grains usually stood out well against the brown of the melanin
pigment, the latter was sometimes so intense as to obscure cell nuclei (Fig. 5C).
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FIG. 3.-Combined growth curve for 11 lung metastases in case 6 (see text).
Repeat autoradiographs were therefore made after bleaching out the melanin
with 0.05% potassium permanganate followed by 0.3% oxalic acid.
Case 7
Border Collie. Bitch. Age 11 years. Weight 17 kg. Thymidinedose 4 mCi.
An adenocarcinoma ofthe fourth left mammary gland was diagnosed. Metastases
were present in the left os calcis, right femur and the caudal vertebrae as well as
in the lungs.
Of the four lung metastases which were measurable, one (number 4) was
visible over a total period of 28 days and had a well-defined doubling time of 18
days. The other three were measurable for a shorter period, were smaller and
may have had a slightly shorter doubling time of 16 days. Only two measure-
ments were possible on metastasis number (3) and these were consistent with the
growth rate of the other secondaries.
Case 8
Miniature Poodle. Female. Age 7 years. Weight 9 kg. Thymidine dose
2 mCi. The animal presented with a tumour in the right inguinal mammary gland
and with metastases in the lungs. Histological diagnosis was spindle cell sarcoma.
The four metastases whose growth could be followed differed widely in size
but they all had volume doubling times of about 40 days.
The autoradiographs from this case presented severe counting problems. The
metastases consisted of large areas of virtually unlabelled acellular tissue with a
few well-labelled islands. Because of the difficulty of making counts which were
representative of the whole tumour, only an upper limit on the labelling index is
given in this case (Table I). It nevertheless seemed that the labelling index in
case 8 was lower than for the other tumours of this series.
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Case 9
Crossbred Alsatian. Male. Age 6 years. Weight 29 kg. Thymidine dose
6 mCi. This animal presented with a firm irregular swelling around the upper
third of the right radius and ulna. Radiographs indicated an osteolytic bone
tumour with numerous lung secondaries, and on biopsy ofthe primary, a diagnosis
of osteosarcoma was made (a very unusual site). Chest radiographs were made
over a period of 46 days, and it was possible to follow the growth of 7 metastases.
Growth curves for 4 ofthese are shown in Fig. 2. The terminal volume doubling
times were estimated to be 11, 25, 40, 26, 20, 37 and 12 days (mean = 24 days).
Biopsies were obtained ofmetastatic lung tumours of a similar size to those which
had been measured radiographically.
STUDIES OF THYMIDINE LABELLING
Tritium-labelled thymidine (TRK.61, Radiochemical Centre, Amersham,
England) was injected intravenously at a specific activity which ranged between
15 and 25 curies/mM. After an interval of 1-2 hours, the animals were destroyed
with pentobarbitone sodium and a thorough post-mortem examination was
performed. Representative specimens of primary and secondary tumours were
fixed in 10% neutral formol saline. In cases where there were many lung meta-
stases great care had to be taken to identify those metastases which had been
measured. The identification of specific metastases was facilitated by inflating
the lungs and comparing the anatomical location of the metastases with their
position as shown on radiographs taken immediately before death.
Paraffin sections were cut at 4, and autoradiographed by the dipping tech-
nique using Ilford K5 emulsion (Lord, 1963). Some slides were prestained by the
Feulgen reaction, others were stained with haematoxylin and eosin after photo-
graphic processing. Test slides were examined after various exposure times; good
labelling was usually found after 1 to 3 months exposure, though some slides had
to be left for up to 6 months (Fig. 5).
Many of the tumours showed extensive macroscopic and microscopic necrosis
and the degree of heterogeneity made it difficult to be sure that counts oflabelled
cells were representative ofthe whole tumour. The standard counting procedure
was as follows. Using an overall magnification of 400 x or 1000 X (oil immersion
objective), counts were made within at least 40 fields defined by an eyepiece
graticule which gave a square field with 16 subdivisions. Fields were selected
with the aid of vernier scales on the microscope stage, giving an array which
covered the specimen in a 1 mm. grid. Within each field the number of
EXPLANATION OF PLATES
FIG. 4.-Post-mortem appearance of lungs from case 6.
FIG. 5. Examples of the autoradiographs from: (A) lung metastases in case 1; (B) intestinal
epithelium in case 1; (C) case 6, showing labelling within a region of heavy pigmentation;
(D) case 1, showing the wide range of grain counts over individual nuclei; (E) labelled cell
and unlabelled mitotic figure (arrowed) in case 5; (F) labelled cells and one labelled mitosis
in case 9.
FIG. 9.-Photomicrographs of the autoradiographs from case 3 showing (A) labelling in a
lung metastasis; (B) labelling in adrenal cortex; (C) labelling in capsule of the kidney;
(D) mitotic figures but no labelling in kidney metastasis. (B), (C) and (D) are from different
parts of the same microscopic slide.
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subdividing squares occupied by viable tissue, the number of labelled cells and the
number of mitotic figures were recorded. In a representative proportion of the
fields an estimate was also made ofthe total number ofnuclei per full microscopic
field; this was the most difficult parameter to measure reliably. From these data
it was possible to calculate the labelling and mitotic indices. The labelling index
results (labelled cells per 100 cells) are given in Table I.
Cell cycle, investigation by the method of labelled Mitoses: cases 5 and 9
Case 5 was selected because the large area of tumour tissue infiltrating skin
made practicable the removal of repeated biopsies. Fifteen of these were taken,
first at about 4-hour intervals and later at about 8-hour intervals up to 3 days
after thymidine injection. The specimens were fairly small and in the auto-
radiographs (3 months exposure) the total number of mitoses found was in the
range 20-50 per specimen. There is a correspondingly large statistical counting
error.
The resulting plot (Fig. 6) of labelled mitoses as a fraction of all mitoses gives
information on the duration of the cell cycle and its constituent phases (Quastler
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FIG. 6.-Labelled mitoses curves from case 5 (top) and case 9 (bottom). The full lines are
the computed best-fitting theoretical curves (see text). For case 9 the circles indicate
counts on lung metastases, the triangles on biopsies of the primary tumour.
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and Sherman, 1959; Mendelsohn, Dohan and Moore, 1960; Steel, Adams and
Barrett, 1966). By comparison with other published labelled mitoses curves in
tumours, that for case 5 shows heavy damping and the first peak is rather poorly
defined. Both of these characteristics are consistent with considerable spread in
the durations ofthe various phases ofthe cell cycle. The data have been analysed
by the method of Barrett (1966). An optimising computer program has been
used (Steel and Hanes, unpublished) in which the means and standard deviations
of G2, S and G1 are varied until a curve is found which has the minimum mean
square deviation from the experimental points. The resulting curve is shown in
Fig. 6. It corresponds to the following values of the phase durations (mean ±
standard deviation in hours; mitotic time is assumed to be 1 hour and to be
included in the means of G1 and G2).
G2 = 5.4 ± 15
S =5-3±1F7
G- = 61 ± 48
The analysis indicates a median cycle time of50 hours, though in view ofthe quality
of the data this value is subject to considerable uncertainty.
The above data must be accepted with some caution. Some of the character-
istics of the labelled mitoses curve of Fig. 6 could also have been produced by
incomplete thymidine labelling. The ratio of the count of labelled nuclei to
mitotic figures was extremely low (about 2) and this might well imply that not all
DNA-synthesising cells were seen to be labelled in the autoradiographs. The fact
that the first peak of the labelled mitoses curve reached 88% implies that of the
cells which were in the middle of their DNA synthetic period at the time of thy-
midine injection, less than about 10% were missed; however, labelled cells could
more easily be missed if they were labelled when at the beginning or end of the
DNA synthetic period since they would probably have a smaller uptake ofthymi-
dine. A further explanation ofthe low ratio oflabelled cells to mitoses could be a
relatively long duration of mitosis. The fact that the first limb of the labelled
mitoses curve rises rather slowly is consistent with this.
The autoradiographs from this case have been repeated with no improvement
in the quality of definition of the curve. Longer exposures than 3 months have
not been used because by this time some nuclei were so heavily labelled as to
prevent the reliable identification of mitosis.
The main conclusion which can be drawn from the data on this case is that
although there are some peculiar features about the labelled mitoses curve, which
may have resulted from great variations in the availability oftritiated thymidine
to individual cells, the duration of DNA synthesis was not more than about 8
hours. The duration of DNA synthesis in this tumour was thus comparable to
values for most tumours in experimental animals (Frindel et al., 1967; Mendelsohn
et al., 1960; Steel et al., 1966) and only perhaps half as long as has been found in
some human tumours (Frindel, Malaise and Tubiana, 1968).
In case 9, an attempt was made to perform a labelled mitoses experiment
actually on lung metastases. This is clearly the ideal experiment since the rest of
the data on growth and labelling index are on lung secondaries; to the knowledge
ofthe authors this has not, however, previously been attempted with spontaneous
lung metastases.
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The animal was first anaesthetised with pentobarbitone sodium given intra-
venously, and placed on a ventilator. 6 mCi of tritiated thymidine was injected
intravenously. A thoracotomy was performed on the right side and the brachial
and brachiocephalic arteries clamped. Pupils dilated after 5 minutes 20 seconds.
The clamp was removed 3 minutes later and the pupils constricted. Following
this brain anoxia no further anaesthetic was required for 12 hours. An intra-
venous drip of 4-3% dextrose and 0-18% sodium chloride was given to balance
fluid loss. Individual lung metastases were removed and biopsies of the primary
were made at intervals until death ofthe animal 20 hours afterthymidine injection.
Autoradiographs prepared after 3 months exposure were of good quality and
the identification of labelled and unlabelled mitotic figures could be made with
confidence. In the lung metastases (Fig. 6) the first peak of the labelled mitoses
curve was well defined and the optimum theoretical curve through the points has
the parameters
G2 = 6-6 ± 4-1 hours
S = 111 ± 26
G- = (not defined)
The labelling index of the earliest biopsies of lung metastases was 97°7%. The
counts on biopsies ofthe primary tumour suggest that the duration and spread of
G2 values were similar to those found for the metastases. However, the points
at 16 and 20 hours show little evidence of a fall in the percentage of labelled
mitoses. It must therefore be concluded that the duration of DNA synthesis in
the primary tumour was in excess of 15 hours.
Evidence for incomplete thymidine labelling: case 3
Many of the tumours in the present series showed considerable heterogeneity.
There were extensive regions of necrosis, regions of infiltration by mononuclear
cells and wide variations in the number of nuclei per unit area of section. Mor-
phological heterogeneity was often reflected in a very non-uniform distribution
of labelled cells. In a few autoradiographs the clear impression was gained that
thymidine labelling dose to blood vessels was high (both in labelling index and
grain count) and that elsewhere it was lower; occasional vessels were found inter-
secting the plane ofthe section around which there was an apparent concentration
of labelled cells. This observation corresponds to the situation which has been
reported in spontaneous and transplanted tumours in the mouse (Kligerman,
Heidenreich and Greene, 1962; Tannock, 1968) and which has largely been
attributed to variations in the availability of metabolites at different distances
from blood vessels, with consequent variations in the rate of cell proliferation.
An observation in case 3 which is disturbing from the point ofview ofthymidine
technique, was that regions within the lung metastases could be found in which
labelling was low or absent but in which mitotic figures were still clearly visible.
An analysis was made of the spatial distribution of labelled cells and mitotic
figures in the metastasis designated (3) and the results are shown in Fig. 7. Using
the standard counting system mentioned earlier, counts of labelled cells and
mitoses were made in array of fields each of size 200 X 200 microns. The distri-
bution for mitotic figures has a variance equal to 1-26 times the mean and it is well
fitted by a Poisson distribution with the same mean (5 75 mitoses/field). It would
therefore seem that in this tumour the mitoses were distributed at random. When
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the same procedure was applied to the labelled cells a wide discrepancy was found;
the experimental variance is 4-6 times the mean and the labelled cells were thus
not randomly distributed. This may be emphasised by the type ofplot shown in
Fig. 8, where for each field the ratio oflabelled cells to mitoses has been calculated
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FIG. 7.-Spatial distribution of mitotic figures and labelled cells in case 3. The broken lines
indicate Poisson distributions having the same mean as the experimental data.
and plotted against the number of labelled cells. There is a clear correlation
between these two parameters, a correlation which should not exist if thymidine
were reaching all proliferating cells. The only possible explanation apart from
incomplete thymidine availability is that in areas of poor metabolite supply the
duration of mitosis was increased and that mitoses may have been arrested. But
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it seems unlikely that this could occur to just the necessary extent to produce a
random distribution of mitotic figures.
Examination of autoradiographs of the kidney also showed tumour cells
which had failed to label. On the first batch of autoradiographs which were
prepared, one metastasis was foundjust beneath the capsule. A detailed examina-
tion revealed clearly labelled cells within the capsule ofthe kidney (Fig. 9) but in
the tumour tissue, which came to within 0 5 mm. ofthe site ofthese labelled cells,
no labelling could be found. This was in spite of the fact that the kidney metas-
tasis had a mitotic index of 0-61 %, comparable with the mitotic indices of the
three measured lung metastases (0.65%, 0.72%, 1.17%). A section of the
adrenal gland on the same slide as the kidney metastases was heavily labelled.
CORRELATION BETWEEN L/M & LABELLING INDEX.
(CASE 3.)
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FIG. 8.-Correlation between the number of labelled cells per mitotic figure and the number of
labelled cells per microscope field in case 3.
The failure of cells within the kidney metastasis to label has been confirmed by
repeated autoradiographs, with up to 6 months exposure. On re-examination of
the post-mortem specimens, four further metastases were found in the kidney.
Autoradiographs were made of these and it was found that one (5 mm. diameter)
contained labelled cells while the other three (diameter 1 mm., 3 mm. and 12 mm.)
were unlabelled. A single metastasis in the heart was well labelled.
The cause of the anomalous labelling in kidney was almost certainly vascular
occlusion due to tumour emboli and to pathological changes with the kidney itself.
The tubules showed necrosis and there was an interstitial nephritis, a common
condition in older dogs. The fact that the kidney was abnormal does not, how-
ever, remove the problems posed by the failure to find labelling in mitotically
active tumour tissue. If the blood supply to a region of the kidney was so poor
as to completely prevent thymidine labelling, how could it be that the mitotic
index was unaffected? Ifsuch a situation could arise inthis pathological situation,
could it not also arise in other cases of regional thrombosis in tumours? It is
possible that the blood supply deteriorated suddenly, just before thymidine
injection, but it would be a coincidence ifthis happened in time to prevent thymi-
dine reaching the tumour but not so long beforehand that mitotic figures could
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disappear. The observation of labelled cells in the capsule is reasonable because
of the separate blood supply which it receives.
The conclusion which can be drawn from the studies of thymidine labelling in
case 3 is that in both the lung and the kidney metastases there is evidence for
incomplete thymidine labelling. In both tissues, regions were found in which the
mitotic index was normal but in which thymidine labelling was much reduced or
absent. The question whether labelling could have been detected by extremely
long exposures cannot be conclusively answered. In the kidney metastases this
is unlikely, because after an autoradiographic exposure of 3 months not one cell
was found to have more than 4 grains. Even ifthe non-uniformity oflabelling in
the lung metastases could be reduced or abolished by long exposures, it would still
remain that the observation of high grain counts over some cells within a tumour
cannot be taken to imply that labelling is everywhere complete. Among the dog
tumours of this series there were other examples of what was apparently a wide
distribution ofgrain counts; as was noted in the discussion ofcase 5 it was difficult
to find an autoradiographic exposure which allowed recognition ofthe low-labelled
cells without heavy labelling obscuring the appearance of other nuclei.
DISCUSSION: COMBINATION OF THE RESULTS ON GROWTH RATE AND
LABELLING INDEX
The measurements of volume doubling time and thymidine labelling index
may be brought together in the type of chart shown in Fig. 10. For tumour cell
populations from which there is no cell loss, the cell population doubling time
should be related to the labelling index (L.I.) and duration of the DNA synthetic
period (ta) by the relation
T LI ... (i)
When applied to tumour cell populations in which cell loss occurs, T has been
called the potential doubling time (Steel, 1967). A theoretical discussion of the
parameter A has been presented (Steel, 1968) where it is shown that although A
has apossible range ofvalues from 0 7 to 1-4, values higher than unity are unlikely,
and when the population doubling time is longer than 2 days, A will be within the
range 0 7 to 0 8. In practice, cell population doubling times can seldom be
measured; usually it is assumed that a volume doubling time gives the same
result. This may not be the case, but it should be noted that most of the factors
which would upset the equivalence ofpopulation and volume doubling time, such
as the progressive accumulation of necrotic material, will tend to make the
doubling time of volume shorter than that of the cell population. With this
qualification, equation (i) allows one to estimate the doubling time which a tumour
should have in the absence of cell loss. Comparison of such a potential doubling
time with the true volume doubling time of a tumour (Td) enables one to deduce
the extent of cell loss. If a cell loss factor is defined as the rate of cell loss as a
fraction of the rate at which cells are being added to the tumour volume, then it
can be shown that
-T Cell loss factor = 1-T ... (ii) (d
(Steel, 1968)
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In Fig. 10 the present measurements of volume doubling time and labelling
index have been plotted together using double-logarithmic coordinates, and on
such a plot the relationship ofequation (i) gives a series ofstraight lines for various
values ofts. These may be called the no-loss relationships and it is to be expected
that experimental points will fall to the right hand side ofthe appropriate no-loss
line to an extent which increases with the cell loss factor. Points which are far
to the right indicate high cell loss.
TUMOURS IN DOMESTIC ANIMALS
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FIG. 10.- Correlation between labelling index and volume doubling time for tumours in
domestic animals. The circles enclosing the case number represent individual lung meta-
stases; the stars represent primary tumours. The full line indicates the no-loss condition
for an assumed S period of 8 hours and the broken lines correspond to cell loss factors of
50% or 90%.
In the present calculations a value ofA of 0 75 has been used and t5 has been
taken to be 8 hours, on the basis of cases 5 and 9. There is some uncertainty in
this figure but the choice of 8 hours is to some extent supported by the available
data on tumours in experimental animals and in man (Lamerton and Steel, 1968).
It can be seen that the results indicate extensive cell loss, particularly in the
metastases of case 2 and in both of the primary tumours. Values of cell loss
factor have been calculated and are given in Table I. It should be emphasised
that the possible error in the calculations of cell loss factor may be considerable.
Apart from the measurement errors of the labelling index and volume doubling
time, the assumptions that t5 is known and constant and that the volume doubling
time reflects the cell population doubling time introduce considerable uncertainty.
The most rational course may be to broadly grade tumours on the basis ofcell loss
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factor. This has been done in Table I where the grades are defined as follows:
Ratio of potential
to observed doubling
Cell loss factor time
Grade I . less than 20% . greater than 8/10
Grade II . 20% to 50% . 8/10 to 1/2
Grade III . 50% to 90% . 1/2 to 1/10
Grade IV . greater than 90% . less than 1/10
The evidence forincompletethymidinelabelling which was particularly clear in
case 3 is a cause for some concern to those who use tritium labelled thymidine in
the study of tumour growth. It appears that in some tumours there is a very
broad distribution of grain counts following a single thymidine injection, and that
it is necessary to expose the autoradiographs until some cells are very heavily
labelled in order to detect a substantial proportion of weakly labelled cells. In a
labelled mitoses experiment this cannot be done without biasing the choice of
mitotic figures. The impression has been gained that this problem is more serious
in canine tumours than in tumours of the rat and mouse, but no satisfactory
comparison of this type has so far been made. It should be noted that if the
labelling indices recorded in Table I are distorted by incomplete thymidine
labelling then the estimates of cell loss factor deduced from them will be too low
rather than too high: the necessity to postulate cell loss arises because too many
labelled cells are seen to explain the observed volume growth rate.
An assumption which is inherent in the present calculations of cell loss factor
is that cells incorporate tritiated thymidine only as a preparation for division. It
is thus assumed that the type of labelling which has been observed by Pelc (1964)
does not occur extensively in tumours. What evidence there is goes against this
possibility: in case 3 the use of mitotic index rather than labelling index would
increase the estimate of cell loss factor, and it should be remembered that the work
of Iversen (1967) and Refsum and Berdal (1967) indicated high cell loss by the
colchicine method.
As regards the comparative aspects of tumour growth rate it is difficult on
such a small number of cases to draw any firm conclusions. In Fig. 1 the volume
doubling times for the present series have been represented on the same scale as
the available human data. If the doubling times of the metastases in each case
are first averaged to give a single value, then the median doubling time for the
primary and secondary animal tumours is about 25 days, somewhat shorter than
the median of 66 days for the human tumours. The difference between the
distributions of doubling time for tumours in domestic animals and man may be
significant (P = 0'05, calculated from the distributions of the logarithm of
doubling time). A comparison oflabelling indices is also consistent with a slightly
higher growth rate in the animal tumours: the median labelling index for the
tumours in the present series is about 5%, as compared with a median of 3% for a
group of 170 human tumours (Steel, 1967). While these differences are in the
direction which one might expect from the differences in lifespan they are neverthe-
less sufficiently small to confirm the basic starting point of this work that spon-
taneous tumours in domestic animals serve as a good model for human cancer.
It can be concluded, therefore, that the tentative hypothesis that in a majority of
human tumours cell loss is the dominant factor determining growth rate has been
to some extent confirmed by the present simultaneous studies of labelling index
and growth rate in spontaneous animal tumours.
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SUMMARY
The growth rate of spontaneously arising tumours has been studied in seven
dogs ofvarious breeds and in one cat. In most cases the measurements were made
on multiple lung metastases, though where possible the growth of the primary
tumour was also followed. The volume doubling times ranged from 7 days to
150 days, on average slightly shorter than the published values of human tumour
doubling times.
Autoradiographic studies of the uptake of tritium-labelled thymidine were
made in all cases. In two cases the technique of labelled mitoses was used: in
one dog, biopsies of infiltrated skin were taken; another dog was kept anaesthe-
tised throughout the experiment and lung metastases and biopsies ofthe primary
tumour were removed at intervals up to 20 hours. There was evidence that in
some canine tumours H3-thymidine did not reach all cells engaged in DNA
synthesis in detectable quantities. In spite ofthis, calculations ofthe rate of cell
production based on the measured thymidine labelling indices were much higher
than was necessary to maintain the observed growth rates. The results therefore
imply that extensive cell loss was taking place from the tumours of domestic
animals. On rather less satisfactory evidence this has previously been suspected
to be the case in a majority of tumours in man.
We are grateful to Mrs. J. Lucas for her skill in the preparation of the auto-
radiographs and to Mr. H. D. Williamson for the radiography of the lung meta-
stases.
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